naf-SILL-in
Therapeutic Classification: anti-infectives
Pharmacologic Classification: penicillinase resistant penicillins
REMS
Spectrum:
Absorption: Completely absorbed following IV administration; well absorbed from IM sites.
Distribution: Widely distributed; penetration into CSF is minimal but sufficient in the presence of inflamed meninges; cross the placenta and enter breast milk.
Protein Binding: 90% to albumin.
Half-Life: Neonates: 1–5 hr; Children 1 mo – 14 yr: 0.75–1.9 hr; Adults: 0.5–1.5 hr (increased in renal impairment).
Contraindicated in:
Use Cautiously in:
GI: diarrhea, epigastric distress, nausea, vomiting, ↑liver enzymes, CLOSTRIDIOIDES DIFFICILE-ASSOCIATED DIARRHEA (CDAD)
GU: acute kidney injury, hematuria, interstitial nephritis, proteinuria
Hemat: eosinophilia, leukopenia
Local: pain at IM site, phlebitis at IV site
Neuro: SEIZURES
Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS AND SERUM SICKNESS), superinfection
Drug-drug:
Lab Test Considerations:
IV Administration:
NDC Code